BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Harvard Business School
McKinsey
Federal Trade Commission
Chinese Patent Office
Express Scripts
McKesson
QuintilesIMS
Johnson and Johnson
Healthtrust

Generated: January 22, 2018

DrugPatentWatch Database Preview

HYDROCODONE BITARTRATE AND ACETAMINOPHEN Drug Profile

« Back to Dashboard

Which patents cover Hydrocodone Bitartrate And Acetaminophen, and when can generic versions of Hydrocodone Bitartrate And Acetaminophen launch?

Hydrocodone Bitartrate And Acetaminophen is a drug marketed by Mallinckrodt, Mikart, Mallinckrodt Inc, Nesher Pharms, Pharm Assoc, Vintage Pharms, Vistapharm, Abhai Llc, Able, Actavis Labs Fl Inc, Amneal Pharms, Amneal Pharms Ny, Apil, Aurolife Pharma Llc, Barr, Caraco, Halsey, Ivax Pharms, Lannett Holdings Inc, Larken Labs Inc, Mutual Pharm, Novel Labs Inc, Par Pharm, Ranbaxy, Ranbaxy Labs Ltd, Rhodes Pharms, Sandoz, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Tris Pharma Inc, Ucb Inc, Upsher-smith Labs, Usl Pharma, Vintage Pharms Llc, Watson Labs, Watson Labs Florida, and Wes Pharma Inc. and is included in one hundred and thirteen NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND ACETAMINOPHEN is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
Drug patent expirations by year for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Pharmacology for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists

US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Holdings Inc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 207171-001 Jun 20, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mikart HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 089689-001 Jun 29, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Ny HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 206869-001 Jun 23, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Able HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 040490-001 May 21, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 081080-001 Aug 30, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vintage Pharms Llc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 040280-002 Sep 30, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mallinckrodt HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 040084-003 Jul 29, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 205001-002 Jul 5, 2016 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vintage Pharms HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 090415-001 Jan 24, 2011 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Ny HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 040757-001 Aug 25, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Accenture
Novartis
McKesson
Fuji
Medtronic
Citi
Cipla
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot